文献速递性传播疾病皮肤感染

抑制ERK/RSK级联可限制沙眼衣原体感染

Inhibition of the Extracellular Signal-Regulated Kinase/Ribosomal S6 Kinase Cascade Limits Chlamydia trachomatis Infection.
PubMed 文献 · J Invest Dermatol · 2020-09-09

本研究探讨靶向细胞外信号调节激酶/核糖体S6激酶(ERK/RSK)级联的抑制剂对沙眼衣原体的作用。结果显示抑制剂显著减少包涵体大小和数量及感染性子代,并与阿奇霉素协同抑制;ERK1/2和RSK1对衣原体感染至关重要,BVD-523在细胞培养和小鼠模型中均抑制感染。

要点

  • ERK/RSK级联抑制剂可减少沙眼衣原体包涵体及感染性子代。
  • ERK1/2和RSK1是沙眼衣原体感染的关键宿主激酶。
  • ERK1/2抑制剂BVD-523在体外和小鼠模型中均抑制衣原体感染。

核心结论

  • ERK/RSK通路在沙眼衣原体感染中起关键作用,其激酶可作为宿主导向治疗的潜在靶点。

研究设计与样本

  • 研究在细胞培养和小鼠模型中评估ERK/RSK级联抑制剂对沙眼衣原体感染的影响。

主要发现

  • 靶向ERK/RSK级联各激酶的抑制剂显著减少包涵体大小和数量及感染性子代数量。
  • 抑制剂的抑制作用在沙眼衣原体血清型D、E、F和L1以及HeLa、McCoy和Vero宿主细胞中均观察到。
  • 所有抑制剂与阿奇霉素联合均对衣原体感染产生协同抑制作用。
  • 小干扰RNA敲低实验表明ERK1/2和RSK1对衣原体感染至关重要。
  • BVD-523(处于II期临床试验的ERK1/2抑制剂)在细胞培养和小鼠模型中均抑制衣原体感染。

临床怎么用

  • 提示靶向宿主ERK/RSK通路可能作为沙眼衣原体感染的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chlamydiatrachomatis is the cause of the most common bacterial sexually transmitted infection worldwide. Azithromycin is effective in treating chlamydial infection; however, resistance to this antibiotic is increasing, and it is important that new therapeutic strategies are developed. In this study, we demonstrated that inhibitors targeting each kinase in the extracellular signal-regulated kinase/ribosomal S6 kinase cascade significantly decreased the size and number of inclusions as well as the number of infectious progeny. The suppressive effects of the inhibitors were observed across the Chlamydia serotypes D, E, F, and L1 and across HeLa, McCoy, and Vero host cells. When combined with azithromycin, all the inhibitors exerted a synergistic suppressive effect on chlamydial infection. Knockdown experiments using small interfering RNA demonstrated that extracellular signal-regulated kinase 1/2 and ribosomal S6 kinase 1 were crucial for chlamydial infection. Moreover, BVD-523, a first-in-class extracellular signal-regulated kinase 1/2 inhibitor currently undergoing a phase II clinical trial, suppressed chlamydial infection both in cell culture and in a mouse model. These observations demonstrated not only that the extracellular signal-regulated kinase/ribosomal S6 kinase pathway plays a critical role in chlamydial infection but also that these kinases have potential as targets for host-directed therapy against C. trachomatis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Xue Y, Chen W, Mai Z, et al. Inhibition of the Extracellular Signal-Regulated Kinase/Ribosomal S6 Kinase Cascade Limits Chlamydia trachomatis Infection. J Invest Dermatol. 2020. PMID: 32918951. doi:10.1016/j.jid.2020.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。